Add-on Treatment to Chemotherapy May Improve Acute Myeloid Leukemia Results

Acute myeloid leukemia (AML) is a type of blood cancer that arises from the blood forming cells of the bone marrow which usually form the white blood cells other than the lymphocytes. They may also form other cells like the red blood cells and the platelets. AML is the most common form of acute leukemia that affects adults. Treatment is with chemotherapy, radiotherapy and stem cell transplant. Targeted therapies are currently being evaluated in clinical trials. Nitric oxide synthase inhibitors could increase the effectiveness of chemotherapy administered for the treatment of acute myeloid leukemia, a type of blood cancer.